66 children died of kidney failure; WHO against the cough syrup of the Indian company – Indian Cough Syrup The Gambia | WHO | Tedros Adhanom Ghebreyesus

New Delhi – The World Health Organization (WHO) has issued a warning about four cough syrups produced by ‘Maiden Pharmaceuticals’ in India in connection with the death of 66 children in the African country of Gambia. There is a warning against cough syrups such as Promethazine Oral Solution, Cofexmaline Infant Cough Syrup, Macoff Infant Cough Syrup and Magrip N Cold Syrup.

The warning came amid suspicion that 66 children under the age of five in The Gambia have died of kidney failure as a result of using these syrups. The head of WHO, Tedros Adhanom Ghebreyesus, said that WHO is investigating the matter with the company and regulatory authorities. The World Health Organization also warned that these drugs could be distributed outside the Gambia.

All four drugs were found to contain excess amounts of diethylene glycol and ethylene glycol. These can cause abdominal pain, vomiting, diarrhoea, headaches and even kidney failure which can lead to death, says WHO.

English Summary: Indian Cough Syrup Investigated After 66 Children Die In Gambia: WHO